Next Article in Journal
Metronidazole-Loaded Chitosan Nanoparticles with Antimicrobial Activity Against Clostridium perfringens
Next Article in Special Issue
Design, Synthesis, and Biological Evaluation of 6″-Modified Apramycin Derivatives to Overcome Aminoglycoside Resistance
Previous Article in Journal
Evaluation of Different Polysaccharide–Iron Complex Preparations In Vitro and In Vivo
Previous Article in Special Issue
Impact of V9302, a Competitive Antagonist of Transmembrane Glutamine Flux on Reversal of Resistance in Breast Cancer Cell Lines
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(3), 293; https://doi.org/10.3390/pharmaceutics17030293
Action Date Notes Link
article html file updated 24 June 2025 17:35 CEST Update https://www.mdpi.com/1999-4923/17/3/293/html
article html file updated 24 February 2025 06:12 CET Update -
article pdf uploaded. 24 February 2025 06:10 CET Updated version of record https://www.mdpi.com/1999-4923/17/3/293/pdf
article xml uploaded. 24 February 2025 06:10 CET Update https://www.mdpi.com/1999-4923/17/3/293/xml
article xml file uploaded 24 February 2025 06:10 CET Update -
article html file updated 23 February 2025 09:34 CET Original file -
article supplementary file uploaded. 23 February 2025 09:32 CET - https://www.mdpi.com/1999-4923/17/3/293#supplementary
article pdf uploaded. 23 February 2025 09:32 CET Version of Record https://www.mdpi.com/1999-4923/17/3/293/pdf-vor
article xml uploaded. 23 February 2025 09:32 CET Update -
article xml file uploaded 23 February 2025 09:32 CET Original file -
Back to TopTop